Introduction
The bacterial flora of cerebral abscesses secondary to chronic infections of the middle ear is usually complex, consisting of a mixture of aerobes and obligate anaerobes. ' In the past penicillin has been recommended as the chemotherapeutic agent of choice in such infections,3 but its use, often in very high doses, has been accompanied by high mortality rates.2 3This is probably due to the frequent presence in such abscesses of Bacteroides fragilis, an obligate anaerobe which is usually highly resistant to penicillin by virtue of drug tolerance and the production of 5-lactamase. 4 Other agents that have been used for treating cerebral abscesses, such as chloramphenicol and lincomycin, have not always eradicated the infection2 1 and are potentially toxic, especially when administered for the long periods that have been traditional in the chemotherapy of these infections.
Recently metronidazole has been used to treat the anaerobic bacterial component of this type of cerebral abscess in a few patients.
We describe here the bacteriological findings in nine patients with otogenic cerebral abscesses and the response to treatment with metronidazole.
Patients and methods
Ten patients were admitted consecutively to the Newcastle regional neurosurgical unit and diagnosed as having an intracranial abscess secondary to chronic middle ear infection. The diagnosis was confirmed and the lesion localised by angiography, ventriculography, and latterly by computerised axial tomography. One patient (case 6) was dead on arrival, having had a cardiac arrest in the ambulance. The remaining nine patients were treated by surgical aspiration of the abscess and in seven cases by the instillation of antibiotics (table I) into the abscess cavity. All the patients were initially treated with metronidazole 400 to 600 mg 8 hourly, orally or intravenously, and penicillin 0 6 g 6 hourly or ampicillin 0-5 g 6 hourly and gentamicin 80 mg 8 hourly, the regimen being subsequently modified according to the bacterial flora found in the abscess. In addition to noting the more frequent occurrence of anaerobic than of aerobic bacteria, we also noticed that B fragilis was invariably present in much larger numbers than the other organisms.
RESPONSE TO TREATMENT
The age and sex of the nine patients who were treated, the site of the abscess, their state of consciousness, and their treatment are set out in table I. All the patients had single abscesses.
All patients subsequently had a mastoidectomy and in two patients (cases 7 and 8) the abscess capsule was later excised. One of these patients (case 9) had a complicated postoperative course, but, after remaining comatose for many weeks, he finally recovered though he had residual cerebellar ataxia. The other patients all made remarkably rapid recoveries and, when aspiration was repeated after 48 hours, no further growth of bacteria was obtained. All these patients recovered completely without any residual neurological deficit. As experience with metronidazole increased the duration of treatment was reduced; the most recently treated patients (cases 9 and 10) did not have antibiotics instilled into the cavity, and in case 10 systemic chemotherapy was given for only two weeks.
Case 1-This 16-year-old boy, who has been described in detail elsewhere, ' Although Tutton' 1 and Pennybacker'6 reported mortality rates in patients with otogenic cerebral abscess of 13 ",, and 6,, respectively, the figures subsequently reported by many authors have been much higher. This led the BMJ to entitle a leading article on this subject "Unfulfilled Expectations in Cerebral Abscesses." '" For example, Garfield3 reported a mortality of 40",, in 200 patients with supratentorial intracranial abscesses, and Shaw and Russell'4 found a mortality of 40,, in 47 patients with cerebellar abscess secondary to chronic infection of the middle ear. The higher mortality rate reported by Garfield3 is not explicable in terms of delay in diagnosis or differences in surgical technique. It does, however, seem likely from the case histories presented that there was a further progression of some of the abscesses despite surgical intervention and chemotherapy. This must have been due to the ineffectiveness of their drug of choice, penicillin, against the bacteria causing these abscesses, in particular B fragilis. Garfield instilled only 10 000 to 20 000 units of penicillin into the abscess cavity, whereas Tutton'5 and Pennybacker' 6 used 500 000 units of penicillin. The resulting very high concentrations of penicillin achieved in the abscess contents by Tutton and Pennybacker might well have been sufficient to kill 3-lactamase producing bacteria that would otherwise be resistant to penicillin. In this respect, it is relevant that many strains of B fragilis produce a highly active >-lactamase.a
Our study has shown that either oral or intravenous administration of metronidazole results in high concentrations of active agent in the pus of cerebral abscesses. This, coupled with the extremely rapid bactericidal activity that has been shown in vitro,' 8 is presumably responsible for the successful clinical and bacteriological results that were obtained. Although only nine patients were studied, three of these were stuporous and two were comatose on admission-preoperative states that in larger studies have been associated with a very high mortality. 14 19 These results suggest that metronidazole is of prime importance in the chemotherapy of the anaerobic component of otogenic cerebral abscesses, in particular B fragilis. The satisfactory response of our most recently treated patients suggests that chemotherapy for much shorter periods than has been recommended may now be sufficient.
